- Home
- IPSC vs IDN Comparison
IPSC vs IDN Comparison
Compare IPSC & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- IDN
- Stock Information
- Founded
- IPSC 2019
- IDN 1994
- Country
- IPSC United States
- IDN United States
- Employees
- IPSC N/A
- IDN N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- IDN Computer Software: Prepackaged Software
- Sector
- IPSC Health Care
- IDN Technology
- Exchange
- IPSC Nasdaq
- IDN Nasdaq
- Market Cap
- IPSC 58.1M
- IDN 46.8M
- IPO Year
- IPSC 2021
- IDN 1999
- Fundamental
- Price
- IPSC $0.54
- IDN $2.83
- Analyst Decision
- IPSC Strong Buy
- IDN Buy
- Analyst Count
- IPSC 5
- IDN 2
- Target Price
- IPSC $3.67
- IDN $3.00
- AVG Volume (30 Days)
- IPSC 735.0K
- IDN 47.6K
- Earning Date
- IPSC 05-20-2025
- IDN 05-13-2025
- Dividend Yield
- IPSC N/A
- IDN N/A
- EPS Growth
- IPSC N/A
- IDN N/A
- EPS
- IPSC N/A
- IDN N/A
- Revenue
- IPSC $6,589,000.00
- IDN $19,997,000.00
- Revenue This Year
- IPSC $833.10
- IDN $7.60
- Revenue Next Year
- IPSC N/A
- IDN $10.02
- P/E Ratio
- IPSC N/A
- IDN N/A
- Revenue Growth
- IPSC 194.81
- IDN 5.77
- 52 Week Low
- IPSC $0.34
- IDN $1.92
- 52 Week High
- IPSC $3.47
- IDN $4.46
- Technical
- Relative Strength Index (RSI)
- IPSC 51.91
- IDN 61.62
- Support Level
- IPSC $0.52
- IDN $2.47
- Resistance Level
- IPSC $0.57
- IDN $2.87
- Average True Range (ATR)
- IPSC 0.03
- IDN 0.17
- MACD
- IPSC 0.00
- IDN 0.03
- Stochastic Oscillator
- IPSC 58.75
- IDN 92.86
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.